【意昂2成立一周年】第二屆亞洲核醫學論壇第三屆亞洲青年交流競賽

李思進                          

山西醫科大學第一醫院

王鐵                            

首都醫科大學附屬北京朝陽醫院

安銳                            

華中科技大學同濟醫學院附屬協和醫院

李方                            

中國醫學科學院北京協和醫院

汪靜                            

第四軍醫大學西京醫院

王輝                            

上海交通大學醫學院附屬新華醫院

Diana Paez

International Atomic Energy Agency (IAEA)

Dong-Soo Lee                   

Seoul National University Hospital, Korea

Hussein Kartamihardja

Padjadjaran University, Bandung, Indonesia

Mizanul Hasan                 

National Institute of Nuclear Medicine & Allied Sciences, Dhaka, Bangladesh

Tomio Inoue

Yokohama City University Hospital

日期

論壇日程

北苑

1號樓

May. 5

Thurs.

Special Lectures for SUMHS專題公開課

主持：黃鋼

12:35-13:05  Radiation Dose Reduction Using a Bismuth-coated Latex Shield over the Eye Lens in Brain SPECT/CT by Jun Hatazawa

13:05-13:35  王輝：影像醫學與你的未來

13:35-14:05  裴元虎👲🏼：學習與人生

14:05-14:30  客座教授聘任儀式

1樓

報告廳

May. 6

Fri.

09:00-10:00   Opening Ceremony開幕式

2樓

報告廳

Keynote Session by India主題報告-印度

10:00-10:03  Indian insights and perspectives on NM Research

10:00-10:25  Role of PET/CT in 18 F- FDG/PET CT for Determination of Pulmonary Tuberculosis Activity

2樓

報告廳

Special Lecture專題講座

Part A

11:00-11:30  Importance and Difficulty of Quantitative Imaging Biomarker

-Introduction of concept of RSNA/QIBA and its internationalization-

11:30-12:00Areas of Cooperation between the IAEA and Member States in the Asian Region

Part B

13:30-14:00  Molecular Imaging and Theranostics in Oncology

14:00-14:30  AOJNMB; Asia Oceania Journal of Nuclear Medicine and Biology

14:30-15:00  The Accreditation Council for Graduate Medical Education (ACGME) Accredited Nuclear medicine residency training program in the United States: Overview and personal experience in the residency training program in Albert Einstein College of Medicine/Montefiore Medical Center

2樓

報告廳

Clinical Application(Radionuclide Therapy)

臨床研究分會場（放射性治療)

15:20-15:40  Optimized radio-iodine treatment of hyperthyroidism

15:40-16:00  The Outcome of Well Differentiated Thyroid Cancer Management at SQUH Oman: Our 25 Years’ Experience

16:00-16:20  Comparison of Fixed Versus Calculated Doses of I-131 for Treatment of Graves’ Disease

16:20-16:40  Clinical impact of software development SUV SPECT

2樓

報告廳

Third Rising NM Professional Challenge

第三屆青年發表競賽

Part A

11:00-11:10  Opening Speech

11:10-11:25  Carotid Intima Media Thickness Can Predicted Haemodynamically Significant Coronary Artery Disease Detected by Myocardial Perfusion Imaging

11:25-11:40  A Comparative Metabolic PETand Perfusion MRI Study for Assessing Abnormal Metabolic Network Activity in Patients with Multiple System Atrophy

11:40-11:55  Clinical Impact of FDG-PET on Diagnosis and Management of Dementia

Part B

13:30-13:45  PSMA as a Theranostic Target for Prostate Cancer Management

13:45-14:00  Value of Thyroglobulin Antibody to Determine Successful Ablation Therapy in Differentiated Thyroid Cancer

14:00-14:15  Usefulness of Organ-based Measurement of Volume Based Parameters on FDG PET in Patients with Differentiated Thyroid Carcinoma

14:15-14:30  Respiratory Gating Schemes for Motion-free Cardiac SPECT

14:30-14:45  The Role of 99mTc-MDP Bone Scintigraphy and Prostate Specific Antigen in Prostate Carcinoma

14:45-15:00  Value of intraventricular synchronism assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients submitted to cardiac resynchronization therapy

Part C

15:15-15:30  Value of SPECT-CT in evaluating for Tc99m-sestamibi-negative parathyroid adenomas

15:30-15:45  Current approaches and recommended radiation protection for pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy

15:45-16:00  Asphericity of FDG uptake on 18F FDG PET/CT provides independent prognostic value in breast cancer patients

16:00-16:15  Clinical value of 18F-FDG PET/CT scan in patients with suspectedrecurrent ovarian cancer: experience of a single institution

16:15-16:30  Positron Emission Mammography for Breast Cancer in Rajavithi Hospital

16:30-16:45  The Selective Internal Radiation Therapy For Liver Cancer with Y-90 Microsphere at Bachmal Hospital

16:45-16:55  Closing Speech

1樓

報告廳

Keynote Session (in Mandarin)華人分會場

13:30-13:40  Opening Speech

13:40-14:00  The development of nuclear cardiology in Taiwan

14:00-14:20  Imaging for Neuroinflammationin Preclinical and Clinical Studies

14:20-14:40  Relationship between 18F-FDG accumulation and FBP1 expression in hepatocellular carcinoma

14:40-15:00  Current role of PET-CT in nasopharyngeal carcinoma

15:00-15:20  Neuroimaging for the diagnosis of Lewy body disease

800

會議室

09:00-13:30 Poster Presentation

13:30-14:10  Walking Poster

 (Cardiovascular System)

14:10-15:20  Walking Poster (Oncology)

15:20-16:40  Walking Poster

(General Nuclear Medicine)

200

會議室

May. 7

Sat.

Basic Research基礎研究

09:00-09:20  Evaluation of Tumor Specific Tracer targeting L-type Amino Acid Transporter 1 (LAT1): 18F-FBPA PET study in Tumor and Inflammation compared to 18F-FDG and 11C-Methionine

09:20-09:40  Researches on Sodium/iodide Symporter in Thyroid Carcinoma:From Bench to Bed-side

09:40-10:00  99mTc-labelled HFn for the detection of vulnerable plaque in ApoE-/- mice

10:00-10:20  Evaluating the response of Cisplatin treated VX2 tumor bearing rabbit lung cancer model by circulating tumor specific DNA and 18F-FDG PET/CT imaging

2樓

報告廳

Clinical Application臨床研究分會場

Oncology 腫瘤學

10:30-10:50 Can We Predict Micro vascular Invasion in HCC on FDG PET-CT?

10:50-11:10  Clinical Correlation between Bone Scan Results, Gleason Score and Serum PSA Level Regarding Patients with Prostatic Carcinoma in ourPopulation

11:10-11:30  The semi quantitative parameters clinical usefulness of F18-Fluorodeoxyglucose positron emission tomography and In-111 ibritumomab tiuxetan scintigraphy as therapeutic response predictor in Y90-ibritumomab tiuxetan therapy

11:30-11:50  Comparison of Tc-99m Labelled Methionine and C-11 Methionine Radiotracer for Biopsy proven Carcinoma Breast

2樓

報告廳

Clinical Application臨床研究分會場

Cardiovascular System 心血管系統

09:00-09:20  Role of Gated SPECT Myocardial Perfusion Imaging in Follow-up of Patients with Coronary Revascularization

09:20-09:40  Renal failure is associated with increased risk of cardiovascular (CV) morbidity and mortality due to an increased risk of ischemic heart disease

09:40-10:00  Predictive Value and Various Patterns of Abnormal ECG-Gated Myocardial Perfusion Imaging For Coronary Artery Disease (CAD) In Male Smokers

10:00-10:20  Clinical Utility of Left Ventricular Ejection Fraction Reserve by Stress Thallium-201 Myocardial Gated Single Photon Emission Computed Tomography in Patients with and Suspected Coronary Artery Disease

1樓

報告廳

Clinical Application臨床研究分會場

PET/CT and SPECT/CT

13:30-13:50  PET-CT-MRI triple fusion and its application in head & neck oncology : an alternative to integrated PET-MRI in developing countries

13:50-14:10  Dynamic F-18-Fluroethyltyrosine (F18- FET) PET-CT in evaluation of Gliomas

14:10-14:30  Impact of 68Ga-DOTA-peptide PET/CT on the Management of Gastrointestinal Neuroendocrine Tumour (GI-NET): National Referral Centre

14:30-14:50  CT Dose Optimization for PET/CT Scans of Oncology Patients

2樓

報告廳

Clinical Application臨床研究分會場

General Nuclear Medicine 普通核醫學

13:30-13:50  Challenges for Nuclear Medicine: Competing With or Complementing Other Specialties?

13:50-14:10  Lymphoscintigraphy in the Diagnosis and Follow Up of Lymph Edema Caused by Lymphatic Filariasis

14:10-14:30  Diagnostic Value of 99mTc-Ethambutol in The Management of Pulmonary Tuberculosis

14:30-14:50  Gastro esophageal Reflux Scintigraphy in Bronchial Asthma and Recurrent Lower Respiratory Tract Infections in Children

14:50-15:10  Quantitative Parameters in Tc-99m Pertechnetate Thyroid Scintigraphy Predicts Increased Gland Uptake Function

15:10-15:30  Determination of Metabolites and Processes Related Impurities for Radio medicines by HPLC-Tandem Mass Spectrometry Methodology

1樓

報告廳

New Technology in Nuclear Medicine新技術發表

14:50-15:05  More than FDG in a Cyclotron Facility – follow GMP while producing Ga68, Cu64, Zr89 and more

15:05-15:20  Technical advantages and challenges for SiPM-BGO based PET

2樓

報告廳

Thydoid Disease甲狀腺疾病分會場

10:20-10:50  ChallengesandStrategiesonRadioiodineTreatmentforDifferentiatedThyroidCarcinoma

10:50-11:10  Clinical Significance of Serial Measurement of Serum Anti Thymoglobulin Antibodies (AT gab) in the Follow up of Differentiated Thyroid Carcinoma

11:10-11:30  The usefulness of thymoglobulin doubling time to determine optimal timing to initiate Lenvatinib therapy: initial experience of six radioactive-iodine-refractory differentiated thyroid cancer

11:30-11:50  Risk Factors Associated with Thyroid Carcinoma in North Pakistan

1樓

報告廳

Sino-Japan Joint Seminar on Nuclear Medicine

中日合同發表會

09:00-09:15  Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site

09:15-09:30  Thyroid Hormone Replacement before I-131 Therapy in Patients with Well-differentiated Thyroid Cancer

09:30-09:45  Influences of different processing methods of SPECT on functional indicators of myocardial perfusion imaging

09:45-10:00  Improved detection of small-sized hepatic metastases using PSF and TOF: phantom and clinical studies

10:00-10:15  TSPO Probe Discovery for Cancer Imaging

10:15-10:30  Evaluation of New PET Tracer of 18F-labeled Peptide Targeting GPC3 for Imaging Hepatocellular Carcinoma

10:45-11:00  Dynamic PET/CT Receptor Imaging Using 68Ga-Labelled asialoglycoprotein

11:00-11:15  Radiation Dose Reduction Using a Bismuth-coated Latex Shield over the Eye Lens in Brain SPECT/CT

800

會議室

ANMB Training SessionANMB考試培訓

13:30-14:00  General Introduction of ANMB

14:00-14:45  ANMB

(multiple choice quizs-MCQs)

14:45-15:30  ANMB(cross sectional anatomy)

800

會議室

09:00-09:30 Poster Presentation

09:30-10:10  Walking Poster (Thyroid Disease)

13:30-15:30  Walking Poster (Neurology）

13:30-15:30Poster Presentation

200

會議室

16:30-17:00  Closing Ceremony閉幕式

2樓

報告廳